Poliovirus

Despite marked progress in global polio eradication, the threat of polio importation into the United States remains; therefore, all children should be protected against the disease. The standard schedule for poliovirus immunization remains 4 doses of inactivated poliovirus vaccine at 2, 4, and 6 through 18 months and 4 through 6 years of age. The minimum interval between doses 1 and 2 and between doses 2 and 3 is 4 weeks, and the minimum interval between doses 3 and 4 is 6 months. The minimum age for dose 1 is 6 weeks. Minimal age and intervals should be used when there is imminent threat of exposure, such as travel to an area in which polio is endemic or epidemic. The final dose in the inactivated poliovirus vaccine series should be administered at 4 through 6 years of age, regardless of the previous number of doses administered before the fourth birthday, and at least 6 months since the last dose was received.

[1]  M. Böttiger Polio immunity to killed vaccine: an 18-year follow-up. , 1990, Vaccine.

[2]  M. Pallansch,et al.  Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[3]  R. Leggiadro Vaccine Refusal, Mandatory Immunization, and the Risk of Vaccine-Preventable Diseases. , 2009 .

[4]  J. Eskola,et al.  Age‐ and dose‐interval‐dependent antibody responses to inactivated poliovirus vaccine , 2001, Journal of medical virology.

[5]  M. Roivainen,et al.  Evolution of newly described enteroviruses , 2011 .

[6]  C. Meschievitz,et al.  Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine. , 1997, The Pediatric infectious disease journal.

[7]  M. Pallansch,et al.  Typing of Human Enteroviruses by Partial Sequencing of VP1 , 1999, Journal of Clinical Microbiology.

[8]  Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination. , 2009, MMWR. Morbidity and mortality weekly report.

[9]  M. Rennels,et al.  Prevention of poliomyelitis: recommendations for use of only inactivated poliovirus vaccine for routine immunization. Committee on Infectious Diseases. American Academy of Pediatrics. , 1999, Pediatrics.

[10]  Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. , 2010, Releve epidemiologique hebdomadaire.

[11]  M. Pallansch,et al.  Molecular Evolution of the Human Enteroviruses: Correlation of Serotype with VP1 Sequence and Application to Picornavirus Classification , 1999, Journal of Virology.

[12]  S. Blomqvist,et al.  Eight Years of Experience with Molecular Identification of Human Enteroviruses , 2008, Journal of Clinical Microbiology.

[13]  J. P. Davis,et al.  Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota. , 2009, The Journal of infectious diseases.

[14]  M. Rennels Need for polio boosters after age two years. , 2009, Vaccine.

[15]  M. Pallansch,et al.  Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico. , 2007, The Journal of infectious diseases.

[16]  R. Sutter,et al.  Poliovirus vaccine-live , 2008 .

[17]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[18]  S. Hewitt,et al.  Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[19]  L. Schonberger,et al.  Control of paralytic poliomyelitis in the United States. , 1984, Reviews of infectious diseases.

[20]  Kimberly M Thompson,et al.  Retrospective Cost‐Effectiveness Analyses for Polio Vaccination in the United States , 2006, Risk analysis : an official publication of the Society for Risk Analysis.